Current practices for postoperative pain management in Europe and the potential role of the fentanyl HCl iontophoretic transdermal system
- PMID: 17156510
- DOI: 10.1017/S026502150600189X
Current practices for postoperative pain management in Europe and the potential role of the fentanyl HCl iontophoretic transdermal system
Abstract
Survey results continue to reveal that postoperative pain is insufficiently managed throughout Europe and the rest of the world. However, the efficient use of existing resources, as well as the introduction of novel technologies, may aid in its improvement. Use of an acute pain service has the potential to improve pain management through specialized patient care and utilization of effective analgesic techniques. Multimodal analgesic techniques, which include adjuvant non-opioids and/or regional analgesic techniques, can provide effective analgesia and reduce the amount of systemic opioids (or obviate the need) for postoperative pain management. Patient-controlled analgesia modalities may also offer improvements to pain management, as in practice they provide pain relief superior to the intermittent administration of bolus doses of opioids. A novel patient-controlled analgesia modality that has been approved by the European Medicines Evaluation Agency (EMEA) for the treatment of acute, moderate-to-severe pain is the needle-free, pre-programmed fentanyl HCl iontophoretic transdermal system. This system was shown in a recent US clinical trial to be comparable in efficacy to a standard regimen of morphine intravenous patient-controlled analgesia. Adverse events associated with the use of the fentanyl iontophoretic transdermal system are generally similar to those experienced by patients using intravenous morphine patient-controlled analgesia. Considerations regarding the selection of patients for treatment with the fentanyl iontophoretic transdermal system are similar to those with other patient-controlled analgesia modalities; sufficient upper limb mobility and alertness are required to operate the system. Utilization of the fentanyl iontophoretic transdermal system, together with the guidance of an effective acute pain service, may lead to improvements in postoperative pain management.
Similar articles
-
Efficacy and safety of fentanyl HCl iontophoretic transdermal system compared with morphine intravenous patient-controlled analgesia for postoperative pain management for patient subgroups.Eur J Anaesthesiol. 2010 May;27(5):433-40. doi: 10.1097/EJA.0b013e3283349d82. Eur J Anaesthesiol. 2010. PMID: 20186064 Clinical Trial.
-
Fentanyl HCl patient-controlled iontophoretic transdermal system for the management of acute postoperative pain.Ann Pharmacother. 2006 Dec;40(12):2178-86. doi: 10.1345/aph.1H135. Ann Pharmacother. 2006. PMID: 17164395 Review.
-
Patients' assessment of the convenience of fentanyl HCl iontophoretic transdermal system (ITS) versus morphine intravenous patient-controlled analgesia (IV PCA) in the management of postoperative pain after major surgery.Pain Manag Nurs. 2009 Sep;10(3):124-33. doi: 10.1016/j.pmn.2007.09.001. Epub 2008 Dec 17. Pain Manag Nurs. 2009. PMID: 19706349 Clinical Trial.
-
Comparison of postoperative pain management using two patient-controlled analgesia methods: nursing perspective.J Adv Nurs. 2009 Jul;65(7):1370-80. doi: 10.1111/j.1365-2648.2009.04991.x. Epub 2009 May 9. J Adv Nurs. 2009. PMID: 19456995
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
Cited by
-
[New substances and applications for postoperative pain therapy].Schmerz. 2008 Jun;22(3):353-67; quiz 368-9. doi: 10.1007/s00482-008-0665-5. Schmerz. 2008. PMID: 18491149 German.
-
Treating skeletal pain: limitations of conventional anti-inflammatory drugs, and anti-neurotrophic factor as a possible alternative.Nat Clin Pract Rheumatol. 2009 Feb;5(2):92-8. doi: 10.1038/ncprheum0982. Nat Clin Pract Rheumatol. 2009. PMID: 19182815 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources